Randomized phase III study of carboplatin and paclitaxel versus vincristine, doxorubicin and cyclophosphamide chemotherapy in intermediate and poor prognosis small cell lung cancer: Preliminary results.

S Baka; S Mullamitha; L Ashcroft; S Nagel; R Board; P Lorigan

Randomized phase III study of carboplatin and paclitaxel versus vincristine, doxorubicin and cyclophosphamide chemotherapy in intermediate and poor prognosis small cell lung cancer: Preliminary results.

S Baka, S Mullamitha, L Ashcroft, S Nagel, R Board, P Lorigan

Research output: Contribution to journal › Article › peer-review

Abstract

42nd Annual Meeting of the American Society of Clinical Oncology, Atlanta,GA, 2‐6 June, 2006

Original language	English
Pages (from-to)	7059
Journal	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Volume	24
Issue number	18_suppl
Publication status	Published - 2006

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Baka, S., Mullamitha, S., Ashcroft, L., Nagel, S., Board, R., & Lorigan, P. (2006). Randomized phase III study of carboplatin and paclitaxel versus vincristine, doxorubicin and cyclophosphamide chemotherapy in intermediate and poor prognosis small cell lung cancer: Preliminary results. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 24(18_suppl), 7059.

Baka, S ; Mullamitha, S ; Ashcroft, L et al. / Randomized phase III study of carboplatin and paclitaxel versus vincristine, doxorubicin and cyclophosphamide chemotherapy in intermediate and poor prognosis small cell lung cancer : Preliminary results. In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 ; Vol. 24, No. 18_suppl. pp. 7059.

@article{c2c319c854e241c69814a5e68dba864c,

title = "Randomized phase III study of carboplatin and paclitaxel versus vincristine, doxorubicin and cyclophosphamide chemotherapy in intermediate and poor prognosis small cell lung cancer: Preliminary results.",

abstract = "42nd Annual Meeting of the American Society of Clinical Oncology, Atlanta,GA, 2‐6 June, 2006",

author = "S Baka and S Mullamitha and L Ashcroft and S Nagel and R Board and P Lorigan",

year = "2006",

language = "English",

volume = "24",

pages = "7059",

journal = "Journal of clinical oncology : official journal of the American Society of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "18_suppl",

}

Baka, S, Mullamitha, S, Ashcroft, L, Nagel, S, Board, R & Lorigan, P 2006, 'Randomized phase III study of carboplatin and paclitaxel versus vincristine, doxorubicin and cyclophosphamide chemotherapy in intermediate and poor prognosis small cell lung cancer: Preliminary results.', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 24, no. 18_suppl, pp. 7059.

Randomized phase III study of carboplatin and paclitaxel versus vincristine, doxorubicin and cyclophosphamide chemotherapy in intermediate and poor prognosis small cell lung cancer: Preliminary results. / Baka, S; Mullamitha, S; Ashcroft, L et al.
In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 24, No. 18_suppl, 2006, p. 7059.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Randomized phase III study of carboplatin and paclitaxel versus vincristine, doxorubicin and cyclophosphamide chemotherapy in intermediate and poor prognosis small cell lung cancer

T2 - Preliminary results.

AU - Baka, S

AU - Mullamitha, S

AU - Ashcroft, L

AU - Nagel, S

AU - Board, R

AU - Lorigan, P

PY - 2006

Y1 - 2006

N2 - 42nd Annual Meeting of the American Society of Clinical Oncology, Atlanta,GA, 2‐6 June, 2006

AB - 42nd Annual Meeting of the American Society of Clinical Oncology, Atlanta,GA, 2‐6 June, 2006

UR - http://www.mendeley.com/research/randomized-phase-iii-study-carboplatin-paclitaxel-versus-vincristine-doxorubicin-cyclophosphamide-ch

M3 - Article

SN - 0732-183X

VL - 24

SP - 7059

JO - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JF - Journal of clinical oncology : official journal of the American Society of Clinical Oncology

IS - 18_suppl

ER -

Baka S, Mullamitha S, Ashcroft L, Nagel S, Board R, Lorigan P. Randomized phase III study of carboplatin and paclitaxel versus vincristine, doxorubicin and cyclophosphamide chemotherapy in intermediate and poor prognosis small cell lung cancer: Preliminary results. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006;24(18_suppl):7059.

Randomized phase III study of carboplatin and paclitaxel versus vincristine, doxorubicin and cyclophosphamide chemotherapy in intermediate and poor prognosis small cell lung cancer: Preliminary results.

Abstract

UN SDGs

Other files and links

Fingerprint

Cite this